[HTML][HTML] Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk

L Morimont, H Haguet, JM Dogné, U Gaspard… - Frontiers in …, 2021 - frontiersin.org
Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Mechanisms of estrogen-induced venous thromboembolism

SN Tchaikovski, J Rosing - Thrombosis research, 2010 - Elsevier
The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …

[HTML][HTML] Coagulation factors and the protein C system as determinants of thrombin generation in a normal population

A Dielis, E Castoldi, HMH Spronk, R Van Oerle… - Journal of Thrombosis …, 2008 - Elsevier
Background: Thrombin generation is a powerful tool to probe overall plasma coagulability.
Objective: To determine which plasma factors influence the various parameters of the …

Low thrombin generation in users of a contraceptive containing estetrol and drospirenone

L Morimont, M Jost, U Gaspard… - The Journal of …, 2023 - academic.oup.com
Objective To compare the impact on thrombin generation of the new combined oral
contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or …

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

M Marchetti, E Castoldi, HMH Spronk… - Blood, The Journal …, 2008 - ashpublications.org
We used the thrombin generation assay to evaluate the hypercoagulable state according to
JAK2 V617F mutational status in essential thrombocythemia (ET) and polycythemia vera …

[HTML][HTML] APC resistance: biological basis and acquired influences

E Castoldi, J Rosing - Journal of thrombosis and haemostasis, 2010 - Elsevier
Proteolytic inactivation of factors Va (FVa) and VIIIa (FVIIIa) by activated protein C (APC) and
its cofactors protein S and factor V (FV) is a key process in the physiological down …

Use of calibrated automated thrombinography±thrombomodulin to recognise the prothrombotic phenotype

Y Dargaud, MC Trzeciak, JC Bordet… - Thrombosis and …, 2006 - thieme-connect.com
There is currently no validated method to detect a prothrombotic phenotype. The question
remains, can tissue factor (TF) induced thrombin generation (TG), as measured with the …

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

C Duckers, P Simioni, L Spiezia, C Radu… - Blood, The Journal …, 2008 - ashpublications.org
Severe factor V (FV) deficiency is associated with mild to severe bleeding diathesis, but
many patients with FV levels lower than 1% bleed less than anticipated. We used calibrated …

[HTML][HTML] Factor V Leiden-independent activated protein C resistance: communication from the plasma coagulation inhibitors subcommittee of the International Society …

GW Moore, E Castoldi, J Teruya, E Morishita… - Journal of Thrombosis …, 2023 - Elsevier
Activated protein C resistance (APC-R) due to the single-nucleotide polymorphism factor V
Leiden (FVL) is the most common cause of hereditary thrombophilia. It is found …

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical …

J Douxfils, L Morimont, AS Delvigne… - Clinical Chemistry and …, 2020 - degruyter.com
Background Regulatory bodies recommend the use of an assay based on the assessment of
the endogenous thrombin potential (ETP) for the investigation of the activated protein C …